No need to panic over Dengvaxia - Malacañang

Senator Joseph Victor “JV” Ejercito

Senator Joseph Victor “JV” Ejercito

"We assure the public that as per the DoH there is currently no reported case of severe dengue infection to the individuals who received one dose of dengue vaccine last year", he added. CVS on Sunday said it planned to buy Aetna for $69 billion.

Sanofi medical director Ruby Dizon said there have been no reported deaths related to the dengue vaccination, contrary to reports claimed by Volunteers Against Crime and Corruption that three have already died.

Thousands of children have been given a vaccine that may worsen the symptoms of the disease it is designed to treat.

The sweeping tax overhaul that passed the U.S. Senate on Saturday contains the Republicans' biggest blow yet to former President Barack Obama's healthcare law, repealing the requirement that all Americans obtain health insurance.

Sales last year came in at €55m, well short of the €200m predicted by analysts - and has headed south in 2017, making just €22m in the first nine months of this year and €4m in the third quarter - a near 90% drop.

Senator Joel Villanueva sought to revive a congressional probe on the dengue vaccination programme to determine whether some health officials should be held responsible "for haphazardly allowing the vaccine to be administered without extensive due diligence on the effects and without waiting for the results of a comprehensive clinical trial".

Health officials called on parents to follow the usual dengue prevention measures, including destroying possible breeding places of mosquitoes, seeking early consultation for fever lasting more than two days, and using mosquito nets and mosquito fogging.

Sanofi - the developer of the drug - had previously described it as "critical" in the fight against the disease.

In 2016, the Philippines became the first country to implement the use of Dengvaxia through a school-based dengue immunization program, which initially covered Grade 4 students in the National Capital Region, Central Luzon, and CALABARZON (Cavite, Laguna, Rizal, Quezon).

Sanofi Global Medical Head Ng Su Pieng said she would not recommend Dengvaxia for those who have not been infected with dengue in the past.

But, the vaccine does the opposite of what it's supposed to do, and actually increases the risk of contracting more severe dengue for those who have never been infected before.

"Of course, rest assured, monitoring is continuing, we are working with the Department of Health, in collaboration, to make sure this is maintained", Pasteue said.

General manager Ching Santos said Sanofi has also already advised doctors to avoid prescribing Dengvaxia to patients they know who have not had dengue infections.

Noticias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.